The suppressor world is about to experience the kind of structural shock that usually takes decades of lobbying and... The post The NFA change that’s about to reshape the suppressor market appeared ...

Santa Cruz County residents have been on edge since January’s battery fire in Moss Landing prompted uncertainty about the safety of battery energy storage systems. On Jan. 16, a battery energy storage ...

The US murder rate fell 20 percent, continuing declines in 2023 and 2024. Among cities, Birmingham, Alabama, gets first prize ...

The SOCOM6 is one of Surefire's new Gen-4 cans. Here's our report after running one on the Surefire ICAR for a week at Hat ...

"The Copenhagen Test" recruits a charming Simu Liu and Melissa Barrera for a complicated yet satisfying spy thriller ...

The Banish 12 is the first truly new shotgun suppressor introduced in recent years, and it has a few things going for it. At just over a pound and 8.5 inches long, it’s lighter and more compact than ...

Brandon Maddox is used to being the vulnerable prey. As owner of Silencer Central, the largest retailer in the nation for gun sound suppressors, he’s familiar with what he calls “political ...

The current version of the Analyzer Test Framework is incompatible with the current versions of CodeAnalysis for suppressortests due to #1175. This was fixed a year ago but no new version was released ...

Silence, ban. A coalition of gun rights groups and three New Jersey residents are suing the Garden State for its ban on owning firearm suppressors. Filed in federal court earlier this month, the ...

** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** In a boon to hunters and shooters ...

On February 6, the Fifth Circuit decided United States v. Peterson, holding that noise suppressors (aka silencers or mufflers) are not protected by the Second Amendment. Written by Chief Judge ...

Ovarian function suppression (OFS) with gonadotropin-releasing hormone agonists (GnRHas) is a standard of care for premenopausal patients with high-risk stage II/III hormone receptor–positive breast ...